Introduction
The coronavirus 2019 (COVID-19) has been spreading rapidly from person to person and causing widespread disease over the world since the end of 2019. The spectrum of COVID-19 virus infection ranges from asymptomatic cases to fatal pneumonia. At the beginning of the pandemic, it was said that the most illnesses due to this virus could be self-limited, with an abrupt onset of fever and respiratory symptoms. With the increase of cases all over the world due to the high transmission rate, more symptoms such as fatigue, myalgia, diarrhea, loss of taste and smell have been described as the typical symptoms of COVID-19, and the high mortality rate has been shown among cases with co-morbid diseases.
The signs, symptoms, or laboratory findings of the effects of this illness on the urinary tract system have not yet been fully described in the literature (5-2). Firstly, Mumm et al found that urinary frequency might be a symptom of COVID-19 (5), then Luciani et al reported three cases of gross hematuria (6). While Sun et al firstly isolated the virus from the urine of a COVID-19 patient (8), Liu et al found that the positive rates of glucosuria and proteinuria may have a role on the differentiation of the severity of COVID-19 (1). According to our knowledge, there have been no reports that COVID-19 patients have been evaluated with a standardized questionnaire about their urinary tract system. In this study, we aimed to show if lower urinary tract symptoms (LUTS) could be symptoms of COVID-19 with validated questionnaires.